Ensitrelvir demonstrates swift SARS-CoV-2 clearance and safety among individuals with asymptomatic, mild, or moderate SARS-CoV-2 infections

In a recent study posted to the medRxiv* preprint server, researchers reported the findings of the phase 2a part of a phase 2/3 study that assessed the safety and efficacy of Ensitrelvir among patients with

LYDEN: Better Hemodynamics With Evolut vs Sapien in ViV

Valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) with a self-expanding Evolut valve was associated with better hemodynamics on echocardiography than a balloon-expandable Sapien valve in patients with small failed surgical valves in the LYDEN trial.

Pancreatic Involvement in COVID-19: What Do We Know?

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. MADRID — There is increasing evidence of the impact that SARS-CoV-2 infection has on patients with diabetes. It involves the relationship

New study shows genes can predict response to arthritis treatment, paves the way for future drug development

New research from Queen Mary University of London, published in Nature Medicine, has shown that molecular profiling of the diseased joint tissue can significantly impact whether specific drug treatments will work to treat rheumatoid arthritis